Rare diseases
Investigational molecules
Locations
A study of peginterferon alfa-2a to improve immune system function during colon cancer surgery
DenmarkComparison of ruxolitinib versus hydroxycarbamide or interferon alfa as first treatment for high-risk polycythemia vera patients
FranceStudy on the Effects and Safety of Bulevirtide, Peginterferon Alfa-2a, and Entecavir in Patients with Chronic Hepatitis D
SwedenStudy on the Safety and Effectiveness of Peginterferon Alfa-2a and Ruxolitinib for Newly Diagnosed Polycythemia Vera Patients
DenmarkStudy on the Safety and Effectiveness of VIR-2218, VIR-3434, and Peginterferon Alfa-2a for Patients with Chronic Hepatitis B
GermanyStudy of Navtemadlin for Patients with Myelofibrosis Resistant to JAK Inhibitors
BulgariaStudy on Bomedemstat for Patients with Essential Thrombocythemia Not Responding to or Intolerant of Hydroxyurea, Comparing with a Drug Combination
BelgiumStudy Comparing Fedratinib with Drug Combination for Myelofibrosis in Patients Previously Treated with Ruxolitinib
AustriaStudy of Peginterferon Alfa-2a for Patients with Extramembranous Glomerulonephritis
FranceStudy on the Effects of Peginterferon Alfa-2a, Tobevibart, and Elebsiran in Patients with Chronic Hepatitis B Infection
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
